2,4-thiazolidinedione has been researched along with Bone Diseases, Metabolic in 1 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riche, DM | 1 |
| King, ST | 1 |
1 review available for 2,4-thiazolidinedione and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Bone loss and fracture risk associated with thiazolidinedione therapy.
Topics: Bone and Bones; Bone Density; Bone Diseases, Metabolic; Diabetes Mellitus, Type 2; Female; Fractures | 2010 |